Toposar
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Toposar, covering 2012-09-24 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma [Phase 1]